Table 1.
Parameters | Value | Range | Reference |
---|---|---|---|
Probabilities Used in the Model | |||
Short-term model | |||
Death | 0.0048 | 0.0015–0.0081 | Colquitt et al21 |
Failure | 0.0840 | 0.0700–0.0970 | Colquitt et al21 |
Complication | 0.1063 | 0.0957–0.1169 | Fox et al20 |
Long-term model | |||
Risk of CV mortality | 0.0174 | Bristow et al11 | |
Relative risk of CV death (CRT vs OMT) |
0.67 | 0.51–0.88 | Colquitt et al21 |
Risk of CV death from hospitalization OMTa CRTb |
0.0001 0.0001 |
0.0001–0.0002 0.0001–0.0001 |
Calculation |
Risk of CV death from non-hospitalization OMTc CRTd |
0.0172 0.0116 |
0.0155–0.0190 0.0104–0.0127 |
Calculation |
Risk of non-CV death from hospitalization | 0.0083 | 0.0075–0.0091 | Krittayaphong et al4 |
Risk of non-CV death from non-hospitalization 65 70 75 80 85 90 95 100 |
0.0052 0.0080 0.0128 0.0203 0.0357 0.0357 0.0357 0.0357 |
Burden of disease in Thai population35 Health statistics36 | |
Risk of hospitalization OMT | 0.037 | 0.025–0.049 | Colquitt et al21 |
Risk of all-cause 30-day readmission | 0.2882 | 0.2594–0.3171 | Thailand database22 |
Risk of infection | 0.0006 | 0–0.0020 | Colquitt et al21 |
Risk of lead displacement | 0.0037 | 0.0033–0.0041 | Colquitt et al21 |
Relative risk of hospitalization (CRT vs OMT) |
0.58 | 0.35–0.96 | Colquitt et al21 |
Costs (THB/USD per cycle) | |||
CRT | 367,710 (11,850.15) |
294,168–441,252 (9,480.12–14,220.17) |
Hospital database23 |
OMT | 3,048 (98.23) |
2,438–3,658 (78.57–117.89) |
|
Hospitalization | 10,518 (338.96) |
8,414–12,621 (271.16–406.74) |
|
Infection | 47,062 (1,516.66) |
37,650–56,474 (1,213.34–1,819.98) |
|
Lead displacement | 10,518 (338.96) |
8,414–12,621 (271.16–406.74) |
|
Perioperative complications | 32,000 (1,031.26) |
25,600–38,400 (825.01–1,237.51) |
|
Utilities | |||
HF stable | 0.750 | 0.675–0.825 | Adena et al23 |
Hospitalization | 0.650 | 0.585–0.715 | Adena et al23 |
CRT implantation | 0.460 | 0.414–0.506 | Neyt et al37 |
Disutility of infection | 0.1 | 0.09–0.11 | Colquitt et al21 |
Notes: a1-month rate of CV death from COMPANION trial = -(In (1–18.83%))/11.9=1.75%; 1-month rate of CV death in hospital in Thailand = -(In (1–9.73%))/12=0.82%; 1-month rate of CV death in hospital in this study = -(In (1–9.73%))/12 =1.75%*0.82%=0.01%; Probability of CV death in hospital = 1-exp(−0.01%)=0.0001; b1-month rate of CV death from COMPANION trial = 1.75%*0.67=1.17% (HR 0.67); 1-month rate of CV death in hospital in Thailand = -(In (1–9.73%))/12=0.82%; 1-month rate of CV death in hospital in this study =1.17%*0.82%=0.01%; Probability of CV death in hospital = 1-exp(−0.01%)=0.0001; c1-month probability of CV death = 1-exp(−1.75%)=0.017; 1-month probability of CV death from non-hospitalization = 0.017–0.0001=0.0172; d1-month probability of CV death = 1-exp(−1.17%)=0.012; 1-month probability of CV death from non-hospitalization = 0.012–0.0001=0.0116.
Abbreviations: CRT, cardiac resynchronization therapy; CV, cardiovascular; OMT, optimal medical therapy; HR, hazard ratio; HF, heart failure; THB, Thai baht; USD, United States dollars.